Table 1.
Comparison between ABO-CLT and ABO-ILT recipients
| Characteristics* | ABO CLT | ABO ILT | p-value |
|---|---|---|---|
| N=19 | N=10 | ||
| Male, N (%) | 10 (53%) | 5 (50%) | 0.99 |
| Age (months), median (IQR) | 13.5 (8.2,20.6) | 8.9 (7.4,11.1) | 0.15 |
| Race, N (%) | 0.51 | ||
| African-American | 3 (16%) | 3 (30%) | |
| Caucasian | 4 (21%) | 0 | |
| Hispanic | 5 (26%) | 3 (30%) | |
| Unknown | 2 (11%) | 0 | |
| White: Other | 5 (26%) | 4 (40%) | |
| Diagnosis, N (%) | 0.48 | ||
| Biliary Atresia | 12 (63%) | 6 (60%) | |
| Cryptogenic Cirrhosis | 1 (5%) | 2 (20%) | |
| Fulminant Liver failure | 1 (5%) | 1 (10%) | |
| Metabolic | 5 (26%) | 1 (10%) | |
| PELD | 0.50 | ||
| ≥ 30 points | 11 (58%) | 4 (40%) | |
| Status 1A | 1 (5%) | 1 (10%) | |
| Status 1 B | 7 (37%) | 5 (50%) | |
| Graft type at transplant | 0.13 | ||
| Whole organ | 14 (74%) | 10 (100%) | |
| Left lateral segment, split | 5 (26%) | 0 | |
*
Compared using Fisher’s exact test or Wilcoxon rank sum test